BNP/CALL/STRYKER CORP./380/0.1/20.12.24 Share Price

Warrant

DE000PC5FYF5

Market Closed - Börse Stuttgart 12:06:47 14/06/2024 pm IST
1.03 EUR -10.43% Intraday chart for BNP/CALL/STRYKER CORP./380/0.1/20.12.24
Current month-3.74%
1 month+47.14%
Date Price Change
14/24/14 1.03 -10.43%
13/24/13 1.15 -4.96%
12/24/12 1.21 0.00%
11/24/11 1.21 +0.83%
10/24/10 1.2 -6.98%

Delayed Quote Börse Stuttgart

Last update June 14, 2024 at 12:06 pm IST

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying STRYKER CORPORATION
IssuerLogo Issuer BNP Paribas BNP Paribas
WKN PC5FYF
ISINDE000PC5FYF5
Date issued 21/02/2024
Strike 380 $
Maturity 20/12/2024 (188 Days)
Parity 10 : 1
Emission price 1.97
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 2.51
Lowest since issue 0.68
Spread 0.05
Spread %4.31%

Company Profile

Stryker Corporation is one of the world's leaders in designing, manufacturing, and selling orthopedic equipments. Net sales break down by family of products as follows: - surgical equipments and neurotechnology products (57.5%): electric motorized surgical instruments, surgical navigation systems, endoscopy equipment, digital imaging systems, neurosurgery equipments, neurovascular devices, etc. The group also offers hospital beds, gurneys, stretchers, and emergency room equipment; - orthopedic implants (42.5%): joint prostheses, traumatology implants, micro-implants, orthopedic cement, orthobiology products, etc. The group also provides spinal implants. At the end of 2022, the group had 48 production sites worldwide. Net sales are distributed geographically as follows: the United States (73.9%), Europe/Middle East/Africa (12.7%), Asia/Pacific (10.2%) and other (3.2%).
Sector
-
More about the company

Ratings for Stryker Corporation

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

Consensus: Stryker Corporation

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
29
Last Close Price
345 USD
Average target price
372.5 USD
Spread / Average Target
+7.98%
Consensus